艾滋病治疗药物呲仑帕奈购买途径
Perampanel is a first-of-its-kind anti-epileptic drug exclusively developed by Eisai. One of the mechanisms of epileptic seizures is mediated by the neurotransmitter glutamate, and this drug is a highly selective, non-competitive AMPA-type receptor antagonist that can reduce neuronal hyperexcitability by targeting glutamate activity at AMPA receptors on the postsynaptic cell membrane. Perampanel is available in tablet form and is taken once daily at bedtime. In addition, oral suspension formulations of the drug have been approved for marketing in the United States and Europe.
Currently, perampanel has been approved in more than 55 countries and regions including the United States, Japan, Europe, and Asia, and is used as an adjuvant treatment for partial seizures (with or without secondary generalized seizures) in patients with epilepsy aged 12 years and above. Eisai has also submitted an application in China for the use of perampanel as an adjuvant treatment for partial seizures in epilepsy, and has been designated for priority review.
Where to buy HIV treatment drugs? Perampanel was approved for sale in China on September 29, 2019, and has now been included in the national medical insurance to provide everyone with government discounts to reduce their financial burden. But even after medical insurance, the price of parampanel remains high, prohibiting many families. However, according to Medical Companion Brigade, parampanel is more suitable for long-term use by patients and more cost-effective than other versions. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Parapanel, please contact Medical Companion Travel for details.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)